(Washington Examiner)—Chevron announced Wednesday it will lay off 800 employees in Midland County, Texas by July 15. Six hundred more are set to be laid off in California by June 1.
The cuts are part of the oil company’s effort to downsize its global workforce by 20% by 2026. Chevron has a major operation in Texas’s Permian Basin.
During the first quarter of this year, Chevron reported earnings of $3.5 billion, which was $2 billion less than 2024’s first quarter. According to the company, this was due to “a net loss of $175 million related to legal reserves and a tax charge due to changes in the energy profits levy in the United Kingdom that were partially offset by the fair value measurement of Hess Corporation shares.”
Chevron is in the process of acquiring Hess in a $53 billion deal.
“Despite changing market conditions, our resilient portfolio, strong balance sheet, and consistent
focus on capital and cost discipline position us to deliver industry-leading free cash flow growth
by 2026,” Chevron CEO Mike Wirth said when the first quarter results were released.
- Read More: washingtonexaminer.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.